A Comprehensive Look at Biomarkers and Clinical Applications
Tau, a key protein in neurodegenerative diseases, is emerging as a critical biomarker in understanding Alzheimer’s disease (AD). Recent advancements in Tau biomarker research are breaking new ground in early diagnosis, prognosis, and treatment monitoring.
This whitepaper explores:
- The evolving role of Tau in neurodegeneration and its relevance to Alzheimer’s disease.
- Insights into key Tau biomarkers, including p-Tau 181, p-Tau 217, and p-Tau 231.
- The latest methods for detecting Tau in blood, cerebrospinal fluid (CSF), and brain imaging.
- How Tau biomarkers are shaping AD research, diagnosis, and treatment strategies.
Gain valuable insights into how Tau biomarkers are transforming Alzheimer’s disease research.